pr-inside.com
Print

Reportlinker Adds Europe Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015



2009-07-02 18:28:03 -

Reportlinker.com announces that a new market research report is available in its catalogue.

Reportlinker Adds Europe Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 : www.reportlinker.com/p0128638/Reportlinker-Adds-Europe-Diabetes- ..

www.reportlinker.com/p0128638/Reportlinker-Adds-Europe-Diabetes- .. : www.reportlinker.com/p0128638/Reportlinker-Adds-Europe-Diabetes- ..

Europe Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015


Summary


This report is an essential source for in-depth information and data relating to Europe diabetes care devices market.

It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in Europe

Scope


- The report provides diabetes care devices information broken down into detailed categories in Europe.

- Total revenues, products sold and end users.

- Market shares of all the key competitors.

- Key pipeline products that are set to shape the market, broken down by sector.

- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.

- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

- Key mergers and acquisitions, partnerships, private equity investments and IPOs.

- Customer, hospitals and physicians data.

Reasons to buy


- Gain a strong understanding of the diabetes care devices market in Europe.

- Evaluate and compare the attractiveness of the market in the region.

- Identify growth segments and opportunities in each industry sector within the region.

- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.

- Analyze the competitiveness of the market in the region and identify hotspots.

- Develop strategies based on the latest product, brand, expansion and research and development news in the region.

- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.

- Identify and analyze the strengths and weaknesses of the industry incumbents in the region.

1 Table of Contents


1 Table of Contents 2


1.1 List of Tables 8


1.2 List of Figures 12


2 Introduction 15


2.1 What Is This Report About? 15


3 Definitions of Markets Covered in the Report 16


3.1 Diabetic Care Devices 16


3.2 Glucose Monitoring Devices 16


3.3 Insulin Delivery 16


4 Diabetes Care Devices in Europe 17


4.1 Diabetes Care Devices, Europe, Overall Revenue ($ mn), 2000-2015 17

4.2 Diabetes Care Devices, Europe, Category Volume (Units), 2000-2015 21

4.3 Diabetes Care Devices, Europe, Company share (2007-2008) 24

5 Diabetes Care Devices In Germany 25


5.1 Diabetes Care Devices, Germany, Overall Revenue ($ mn), 2000-2015 25

5.2 Diabetes Care Devices, Germany, Category Volume (Units), 2000-2015 28

5.3 Diabetes Care Devices, Germany, Distribution Share (2007-2008) 31

5.3.1 Glucose Monitoring Distribution Share (2007-2008) 31

5.3.2 Insulin Delivery Distribution Share (2007-2008) 31

5.4 Diabetes Care Devices, Germany, Company Share (2007-2008) 32

5.4.1 Diabetes Care Devices, Germany, Company Share (2007-2008) 32

5.4.2 Glucose Monitoring, Germany, Company Share (2007-2008) 33

5.4.3 Insulin Delivery, Germany, Company Share (2007-2008) 34

6 Diabetes Care Devices In Italy 35


6.1 Diabetes Care Devices, Italy, Overall Revenue ($ mn), 2000-2015 35

6.2 Diabetes Care Devices, Italy, Category Volume (Units), 2000-2015 39

6.3 Diabetes Care Devices, Italy, Distribution Share (2007-2008) 42

6.3.1 Glucose Monitoring Distribution Share (2007-2008) 42

6.3.2 Insulin Delivery Distribution Share (2007-2008) 42

6.4 Diabetes Care Devices, Italy, Company Share (2007-2008) 43

6.4.1 Diabetes Care Devices, Italy, Company Share (2007-2008) 43

6.4.2 Glucose Monitoring, Italy, Company Share (2007-2008) 44

6.4.3 Insulin Delivery, Italy, Company Share (2007-2008) 45

7 Diabetes Care Devices In France 46


7.1 Diabetes Care Devices, France, Overall Revenue ($ mn), 2000-2015 46

7.2 Diabetes Care Devices, France, Category Volume (Units), 2000-2015 49

7.3 Diabetes Care Devices, France, Distribution Share (2007-2008) 52

7.3.1 Glucose Monitoring Distribution Share (2007-2008) 52

7.3.2 Insulin Delivery Distribution Share (2007-2008) 52

7.4 Diabetes Care Devices, France, Company Share (2007-2008) 53

7.4.1 Diabetes Care Devices, France, Company Share (2007-2008) 53

7.4.2 Glucose Monitoring, France, Company Share (2007-2008) 54

7.4.3 Insulin Delivery, France, Company Share (2007-2008) 55

8 Diabetes Care Devices In United Kingdom 56


8.1 Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015 56

8.2 Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2015 59

8.3 Diabetes Care Devices, United Kingdom, Distribution Share (2007-2008) 62

8.3.1 Glucose Monitoring Distribution Share (2007-2008) 62

8.3.2 Insulin Delivery Distribution Share (2007-2008) 62

8.4 Diabetes Care Devices, United Kingdom, Company Share (2007-2008) 63

8.4.1 Diabetes Care Devices, United Kingdom, Company Share (2007-2008) 63

8.4.2 Glucose Monitoring, United Kingdom, Company Share (2007-2008) 64

8.4.3 Insulin Delivery, United Kingdom, Company Share (2007-2008) 65

9 Diabetes Care Devices In Spain 66


9.1 Diabetes Care Devices, Spain, Overall Revenue ($ mn), 2000-2015 66

9.2 Diabetes Care Devices, Spain, Category Volume (Units), 2000-2015 69

9.2.1 Diabetes Care Devices, Spain, Distribution Share (2007-2008) 72

9.2.2 Glucose Monitoring Distribution Share (2007-2008) 72

9.2.3 Insulin Delivery Distribution Share (2007-2008) 72

9.3 Diabetes Care Devices, Spain, Company Share (2007-2008) 73

9.3.1 Diabetes Care Devices, Spain, Company Share (2007-2008) 73

9.3.2 Glucose Monitoring, Spain, Company Share (2007-2008) 74

9.3.3 Insulin Delivery, Spain, Company Share (2007-2008) 75

10 Diabetes Care Devices In Netherlands 76


10.1 Diabetes Care Devices, Netherlands, Overall Revenue ($ mn), 2000-2015 76

10.2 Diabetes Care Devices, Netherlands, Category Volume (Units), 2000-2015 80

10.3 Diabetes Care Devices, Netherlands, Distribution Share (2007-2008) 83

10.3.1 Glucose Monitoring Distribution Share (2007-2008) 83

10.3.2 Insulin Delivery Distribution Share (2007-2008) 83

10.4 Diabetes Care Devices, Netherlands, Company Share (2007-2008) 84

10.4.1 Diabetes Care Devices, Netherlands, Company Share (2007-2008) 84

10.4.2 Glucose Monitoring, Netherlands, Company Share (2007-2008) 85

10.4.3 Insulin Delivery, Netherlands, Company Share (2007-2008) 86

11 Diabetes Care Devices In Belgium 87


11.1 Diabetes Care Devices, Belgium, Overall Revenue ($ mn), 2000-2015 87

11.2 Diabetes Care Devices, Belgium, Category Volume (Units), 2000-2015 90

11.3 Diabetes Care Devices, Belgium, Distribution Share (2007-2008) 93

11.3.1 Glucose Monitoring Distribution Share (2007-2008) 93

11.3.2 Insulin Delivery Distribution Share (2007-2008) 93

11.4 Diabetes Care Devices, Belgium, Company Share (2007-2008) 94

11.4.1 Diabetes Care Devices, Belgium, Company Share (2007-2008) 94

11.4.2 Glucose Monitoring, Belgium, Company Share (2007-2008) 95

11.4.3 Insulin Delivery, Belgium, Company Share (2007-2008) 96

12 Overview of Key Companies in Europe Diabetes Care Devices Market 97


12.1 F. Hoffmann-La Roche Ltd. 97

12.1.1 Company Overview 97


12.1.2 Value Chain Analysis 98


12.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 100

12.2 Bayer HealthCare AG 101


12.2.1 Company Overview 101


12.2.2 Value Chain Analysis 102


12.2.3 Bayer HealthCare AG Pipeline Products 104


12.3 LifeScan, Inc. 105


12.3.1 Company Overview 105


12.3.2 LifeScan, Inc. Pipeline Products 105


12.4 Abbott Laboratories 107


12.4.1 Company Overview 107


12.4.2 Value Chain Analysis 108


12.4.3 Abbott Laboratories Pipeline Products 110


12.5 Medtronic, Inc. 112


12.5.1 Company Overview 112


12.5.2 Value Chain Analysis 113


12.5.3 Medtronic, Inc. Pipeline Products 115


12.6 Novo Nordisk A/S 123


12.6.1 Company Overview 123


12.6.2 Novo Nordisk A/S Pipeline Products 123


12.7 ARKRAY, Inc. 125


12.7.1 Company Overview 125


12.7.2 ARKRAY, Inc. Pipeline Products 125


12.8 Becton, Dickinson and Company 127


12.8.1 Company Overview 127


12.8.2 Value Chain Analysis 127


12.9 Eli Lilly and Company 129


12.9.1 Company Overview 129


12.9.2 Value Chain Analysis 129


12.9.3 Eli Lilly and Company Pipeline Products 132


12.10 Terumo Corporation 133


12.10.1 Company Overview 133


12.10.2 Value Chain Analysis 133


12.11 Animas Corporation 135


12.11.1 Company Overview 135


12.12 Sanofi-Aventis 135

12.12.1 Company Overview 135


12.13 Smiths Medical 136


12.13.1 Company Overview 136


12.13.2 Value Chain Analysis 137


12.14 Apex Biotechnology Corp. 139


12.14.1 Company Overview 139


12.15 Panasonic Corporation 139


12.15.1 Company Overview 139


12.16 A. Menarini Diagnostics S.r.l. 140


12.16.1 Company Overview 140


12.16.2 A. Menarini Diagnostics S.r.l. Pipeline Products 140


12.17 EKF-diagnostic GmbH 142

12.17.1 Company Overview 142


12.18 Diabetes Management International BV 142


12.18.1 Company Overview 142


13 Financial Deals Landscape 143


13.1 Partnerships 143


13.1.1 Amylin Pharmaceuticals Plans to Enter Into an Agreement with Eli Lilly 143


14 Appendix 144


14.1 Global Markets Direct Research Methodology 144


14.2 Coverage 145


14.3 Secondary Research 145


14.4 Primary Research 146


14.5 Models 146


14.6 Forecasts 147


14.7 Expert Panel Validation 147


14.8 Currency Conversion 148


14.9 Contact Us 149


14.10 Disclaimer 149


To order this report:

Reportlinker Adds Europe Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 : www.reportlinker.com/p0128638/Reportlinker-Adds-Europe-Diabetes- ..

www.reportlinker.com/p0128638/Reportlinker-Adds-Europe-Diabetes- .. : www.reportlinker.com/p0128638/Reportlinker-Adds-Europe-Diabetes- ..

More market research reports here! : www.reportlinker.com

ReportlinkerNicolas: nbo@reportlinker.com : mailto:nbo@reportlinker.com US:

(805)-652-2626Intl: +1 805-652-2626

Author:
Hossam Abdel-Kader
e-mail
Web: http://www.pr-inside.com/
Telefon: +43 1 9582319




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.